The Editor-in Chief for DHR Proceedings weights on the decision to stop the administration of the Johnson and Johnson Jansen's COvid-19 vaccine.
Full Issue
Editorial
Is the Public Outcry for Johnson & Johnson Jansen’s COVID-19 Vaccine Causing Blood Clots Justified?
Abstract 228 | PDF Downloads 239Page 1-2